Literature DB >> 26343412

Vascularized tissue transfer in head and neck surgery: Is intensive care unit-based management necessary?

Aru Panwar1,2, Russell Smith1,2, Daniel Lydiatt1,2, Robert Lindau1,2, Aaron Wieland1,2, Alan Richards1,2, Valerie Shostrom3, Oleg Militsakh1,2, William Lydiatt1,2.   

Abstract

OBJECTIVES/HYPOTHESIS: To study the impact of a non-intensive care unit (ICU)-based postoperative management strategy on patient outcomes following vascularized free tissue transfer for head and neck surgical defects. STUDY
DESIGN: Retrospective cohort study.
METHODS: The patients consisted of two groups of adults who underwent vascularized free tissue transfer for head and neck reconstruction between July 2007 and June 2012, at an academic and a community-based hospital. By protocol, the first group of patients had a planned admission to the intensive care unit. After creation of a designated head and neck surgical unit, the second group was cared for in a protocol driven, non-ICU setting. Outcomes and costs were compared between the two patient groups.
RESULTS: There was no adverse impact on flap survival, inpatient morbidity, or mortality with the implementation of postoperative care outside of an ICU. The patients who stayed in the ICU in the immediate postoperative period had a longer median length of hospital stay (ICU vs. non-ICU, 8 days [interquartile range {IQR}= 7-11 days] vs. 7 days [IQR = 6-9.5 days], P = .001). Median hospital charges and cost of care for patients who received ICU-based care (US$109,367 [IQR = US$88,112-US$130,833] and US$33,642 [IQR = US$28,143-US$43,196], respectively) were significantly higher than those for non-ICU-based care (US$86,195 [IQR = US$71,208-US$101,199] and US$28,524 [IQR = US$22,611-US$33,226], P < .0001).
CONCLUSIONS: We demonstrate that care in a non-intensive care setting following vascularized free tissue transfer is safe, less costly, and decreases length of hospital stay compared to routine intensive care-based management.
© 2015 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Head and neck; cost; free flap; intensive care unit; length of stay; microvascular reconstruction; outcomes; postoperative care; vascularized tissue transfer

Mesh:

Year:  2015        PMID: 26343412     DOI: 10.1002/lary.25608

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  5 in total

1.  Factors contributing to surgical site infection in patients with oral cancer undergoing microvascular free flap reconstruction.

Authors:  Sheng-Chiao Lin; Ting-Shou Chang; Kuo-Chung Yang; Yaoh-Shiang Lin; Yu-Hsuan Lin
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-06-09       Impact factor: 2.503

2.  Current practices in microvascular reconstruction in otolaryngology-head and neck surgery.

Authors:  Kevin J Kovatch; John E Hanks; Jayne R Stevens; Chaz L Stucken
Journal:  Laryngoscope       Date:  2018-09-08       Impact factor: 3.325

3.  Free Flap Reconstruction Monitoring Techniques and Frequency in the Era of Restricted Resident Work Hours.

Authors:  Urjeet A Patel; David Hernandez; Yelizaveta Shnayder; Mark K Wax; Matthew M Hanasono; Joshua Hornig; Tamer A Ghanem; Matthew Old; Ryan S Jackson; Levi G Ledgerwood; Patrik Pipkorn; Lawrence Lin; Adrian Ong; Joshua B Greene; James Bekeny; Yin Yiu; Salem Noureldine; David X Li; Joel Fontanarosa; Evan Greenbaum; Jeremy D Richmon
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-08-01       Impact factor: 6.223

4.  Postoperative care in an intermediate-level medical unit after head and neck microvascular free flap reconstruction.

Authors:  Phoebe K Yu; Rosh K V Sethi; Vinay Rathi; Sidharth V Puram; Derrick T Lin; Kevin S Emerick; Marlene L Durand; Daniel G Deschler
Journal:  Laryngoscope Investig Otolaryngol       Date:  2018-11-28

5.  Postoperative care in ICU versus non-ICU after head and neck free-flap surgery: a systematic review and meta-analysis.

Authors:  Mubarak Ahmed Mashrah; Linhu Ge; Taghrid Aldhohrah; Ahmed Abdelrehem; Bahia Sabri; Hyat Ahmed; Natheer H Al-Rawi; Tian Yu; Shiyong Zhao; Liping Wang
Journal:  BMJ Open       Date:  2022-01-06       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.